Author: Arshiya Merchant
Early findings from a phase 3 clinical trial report promising results
Early findings from a phase 3 clinical trial testing DCVax®-L, a dendritic cell treatment, show increased overall survival for patients with glioblastoma.
Research work placement at UCL
Are you aged 16-17, in full time education, and would like to gain experience working in a laboratory focusing on research into brain tumours? Do you know someone who is?